Solid Organ Transplantation and Bariatric Surgery

  • Levan Tsamalaidze
  • Enrique F. Elli


Obesity increases the risk for metabolic syndrome, diabetes, chronic kidney disease, cardiomyopathy, heart failure, fatty liver disease, and certain types of cancer while also causing increased health-care costs. Diabetes, often correlated with obesity, can result in chronic kidney disease and end-stage renal failure, while obesity itself can aggravate end-stage liver disease or cause nonalcoholic steatohepatitis (NASH). Bariatric surgery has demonstrated its safety and efficacy and may be beneficial for both pre- and posttransplant patients. Due to insufficient information in the literature about bariatric surgery in transplant patients, no definitive, ideal procedure exists. In this chapter, we evaluate features and outcomes of bariatric procedures (pre-, during, and posttransplant) in obese patients with solid organ (kidney, liver, and heart) transplantation. According to literature review and analysis, pure restrictive laparoscopic sleeve gastrectomy has demonstrated its superiority over the restrictive and malabsorptive Roux-en-Y gastric bypass operation in terms of safety, technical ease, and efficacy in transplant patients.


Solid organ transplantation Kidney transplantation Liver transplantation Heart transplantation Bariatric surgery Sleeve gastrectomy Roux-en-Y gastric bypass 


  1. 1.
    Androutsos G, Diamantis A, Vladimiros L. The first leg transplant for the treatment of a cancer by Saints Cosmas and Damian. J BUON. 2008;13(2):297–304.PubMedGoogle Scholar
  2. 2.
    Saraf S, Parihar R. Sushruta: the first plastic surgeon in 600 BC. Internet J Plast Surg. 2006;4(2)Google Scholar
  3. 3.
    Morris P, Joseph E. Murray (1919–2012). Nature. 2013;493(7431):164.PubMedGoogle Scholar
  4. 4.
    Starzl TE. Peter Brian Medawar: father of transplantation. J Am Coll Surg. 1995;180(3):332–6.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Borel J, Kis Z, Beveridge T. The history of the discovery and development of cyclosporine (Sandimmune®). Search Anti-Inflammatory Drugs Springer. 1995:27–63.Google Scholar
  6. 6.
    Barnard CN. The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J. 1967;41(48):1271–4.PubMedGoogle Scholar
  7. 7.
    Choban PS, Flancbaum L. The impact of obesity on surgical outcomes: a review. J Am Coll Surg. 1997;185(6):593–603.PubMedCrossRefGoogle Scholar
  8. 8.
    Gore JL, Pham PT, Danovitch GM, Wilkinson AH, Rosenthal JT, Lipshutz GS, et al. Obesity and outcome following renal transplantation. Am J Transplant. 2006;6(2):357–63.PubMedCrossRefGoogle Scholar
  9. 9.
    Meier-Kriesche HU, Arndorfer JA, Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation. 2002;73(1):70–4.PubMedCrossRefGoogle Scholar
  10. 10.
    Nair S, Verma S, Thuluvath PJ. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology. 2002;35(1):105–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Griepp RB, Stinson EB, Bieber CP, Reitz BA, Copeland JG, Oyer PE, et al. Control of graft arteriosclerosis in human heart transplant recipients. Surgery. 1977;81(3):262–9.PubMedGoogle Scholar
  12. 12.
    Storm AC, Lakdawala NK, Thompson CC. Intragastric balloon for management of morbid obesity in a candidate for heart transplantation. J Heart Lung Transplant. 2017;36(7):820–1.PubMedCrossRefGoogle Scholar
  13. 13.
    Takata MC, Campos GM, Ciovica R, Rabl C, Rogers SJ, Cello JP, et al. Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation. Surg Obes Relat Dis. 2008;4(2):159–64;discussion 64-5.PubMedCrossRefGoogle Scholar
  14. 14.
    Gazzetta PG, Bissolati M, Saibene A, Ghidini CGA, Guarneri G, Giannone F, et al. Bariatric surgery to target obesity in the renal transplant population: preliminary experience in a single center. Transplant Proc. 2017;49(4):646–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Carandina S, Genser L, Bossi M, Montana L, Cortes A, Seman M, et al. Laparoscopic sleeve gastrectomy in kidney transplant candidates: a case series. Obes Surg. 2017;27(10):2613–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Al-Bahri S, Fakhry TK, Gonzalvo JP, Murr MM. Bariatric surgery as a bridge to renal transplantation in patients with end-stage renal disease. Obes Surg. 2017. [Epub ahead of print].Google Scholar
  17. 17.
    Fletcher S, Buring J, Goodman SN, Goodridge A, Guthrie H, Hagan D, et al. Methods for voluntary weight loss and control. Ann Intern Med. 1993;119(7 II):764–70.Google Scholar
  18. 18.
    Picot J, Jones J, Colquitt J, Gospodarevskaya E, Loveman E, Baxter L, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess (Winchester, England). 2009;13(41):1–190.Google Scholar
  19. 19.
    Livingston EH. Obesity and its surgical management. Am J Surg. 2002;184(2):103–13.PubMedCrossRefGoogle Scholar
  20. 20.
    Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N. Bariatric surgery worldwide 2013. Obes Surg. 2015;25(10):1822–32.PubMedCrossRefGoogle Scholar
  21. 21.
    Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.PubMedCrossRefGoogle Scholar
  22. 22.
    Payne JH, Dewind LT, Commons RR. Metabolic observations in patients with jejunocolic shunts. Am J Surg. 1963;106:273–89.PubMedCrossRefGoogle Scholar
  23. 23.
    Lim CP, Fisher OM, Falkenback D, Boyd D, Hayward CS, Keogh A, et al. Bariatric surgery provides a “bridge to transplant” for morbidly obese patients with advanced heart failure and may obviate the need for transplantation. Obes Surg. 2016;26(3):486–93.PubMedCrossRefGoogle Scholar
  24. 24.
    Kjellstrant CM. Side effects of steroids and their treatment. Transplant Proc. 1975;7(1):123–9.PubMedGoogle Scholar
  25. 25.
    Laish I, Braun M, Mor E, Sulkes J, Harif Y, Ben Ari Z. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl. 2011;17(1):15–22.PubMedCrossRefGoogle Scholar
  26. 26.
    el-Agroudy AE, Wafa EW, Gheith OE, Shehab el-Dein AB, Ghoneim MA. Weight gain after renal transplantation is a risk factor for patient and graft outcome. Transplantation. 2004;77(9):1381–5.PubMedCrossRefGoogle Scholar
  27. 27.
    Beckmann S, Nikolic N, Denhaerynck K, Binet I, Koller M, Boely E, et al. Evolution of body weight parameters up to 3 years after solid organ transplantation: the prospective Swiss Transplant Cohort Study. Clin Transpl. 2017;31(3)Google Scholar
  28. 28.
    El Atrache MM, Abouljoud MS, Divine G, Yoshida A, Kim DY, Kazimi MM, et al. Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome. Clin Transpl. 2012;26(5):E505–12.CrossRefGoogle Scholar
  29. 29.
    Valantine H. Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J Heart Lung Transplant. 2004;23(5 Suppl):S187–93.PubMedCrossRefGoogle Scholar
  30. 30.
    Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Elli EF, Gonzalez-Heredia R, Sanchez-Johnsen L, Patel N, Garcia-Roca R, Oberholzer J. Sleeve gastrectomy surgery in obese patients post-organ transplantation. Surg Obes Relat Dis. 2016;12(3):528–34.PubMedCrossRefGoogle Scholar
  32. 32.
    Knight GC, Macris MP, Peric M, Duncan JM, Frazier OH, Cooley DA. Cyclosporine A pharmacokinetics in a cardiac allograft recipient with a jejuno-ileal bypass. Transplant Proc. 1988;20(3 Suppl 3):351–5.PubMedGoogle Scholar
  33. 33.
    Rogers CC, Alloway RR, Alexander JW, Cardi M, Trofe J, Vinks AA. Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study. Clin Transpl. 2008;22(3):281–91.CrossRefGoogle Scholar
  34. 34.
    Alexander JW, Goodman H. Gastric bypass in chronic renal failure and renal transplant. Nutr Clin Pract Off Publ Am Soc Parenter Enteral Nutr. 2007;22(1):16–21.CrossRefGoogle Scholar
  35. 35.
    Szomstein S, Rojas R, Rosenthal RJ. Outcomes of laparoscopic bariatric surgery after renal transplant. Obes Surg. 2010;20(3):383–5.PubMedCrossRefGoogle Scholar
  36. 36.
    Al-Sabah S, Christou NV. Laparoscopic gastric bypass after cardiac transplantation. Surg Obes Relat Dis. 2008;4(5):668–70.PubMedCrossRefGoogle Scholar
  37. 37.
    Salinas A, Mc Quattie Pimentel AC, Salinas HM. Roux-en-Y gastric bypass as metabolic treatment in a heart transplant patient with type 2 diabetes: 4 years later. Surg Obes Relat Dis. 2014;10(6):e81–3.PubMedCrossRefGoogle Scholar
  38. 38.
    Al-Nowaylati AR, Al-Haddad BJ, Dorman RB, Alsaied OA, Lake JR, Chinnakotla S, et al. Gastric bypass after liver transplantation. Liver Transpl. 2013;19(12):1324–9.PubMedCrossRefGoogle Scholar
  39. 39.
    Yang X, Yang G, Wang W, Chen G, Yang HA. Meta-analysis: to compare the clinical results between gastric bypass and sleeve gastrectomy for the obese patients. Obes Surg. 2013;23(7):1001–10.PubMedCrossRefGoogle Scholar
  40. 40.
    Boza C, Salinas J, Salgado N, Perez G, Raddatz A, Funke R, et al. Laparoscopic sleeve gastrectomy as a stand-alone procedure for morbid obesity: report of 1,000 cases and 3-year follow-up. Obes Surg. 2012;22(6):866–71.PubMedCrossRefGoogle Scholar
  41. 41.
    Khoraki J, Katz MG, Funk LM, Greenberg JA, Fernandez LA, Campos GM. Feasibility and outcomes of laparoscopic sleeve gastrectomy after solid organ transplantation. Surg Obes Relat Dis. 2016;12(1):75–83.PubMedCrossRefGoogle Scholar
  42. 42.
    Elli EF, Masrur MA, Giulianotti PC. Robotic sleeve gastrectomy after liver transplantation. Surg Obes Relat Dis. 2013;9(1):e20–2.PubMedCrossRefGoogle Scholar
  43. 43.
    Lin MY, Tavakol MM, Sarin A, Amirkiai SM, Rogers SJ, Carter JT, et al. Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation. Surg Endosc. 2013;27(1):81–5.PubMedCrossRefGoogle Scholar
  44. 44.
    Velez JP, Arias RH, Olaya P. Laparoscopic sleeve gastrectomy on heart transplant recipient with body mass index of 34 kg/m2 and metabolic syndrome. Surg Obes Relat Dis. 2012;8(1):e6–7.PubMedCrossRefGoogle Scholar
  45. 45.
    Ablassmaier B, Klaua S, Jacobi CA, Muller JM. Laparoscopic gastric banding after heart transplantation. Obes Surg. 2002;12(3):412–5.PubMedCrossRefGoogle Scholar
  46. 46.
    Chan G, Garneau P, Hajjar R. The impact and treatment of obesity in kidney transplant candidates and recipients. Can J Kidney Health Dis. 2015;2:26.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Heimbach JK, Watt KD, Poterucha JJ, Ziller NF, Cecco SD, Charlton MR, et al. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease. Am J Transplant. 2013;13(2):363–8.PubMedCrossRefGoogle Scholar
  48. 48.
    Nesher E, Mor E, Shlomai A, Naftaly-Cohen M, Yemini R, Yussim A, et al. Simultaneous liver transplantation and sleeve gastrectomy: prohibitive combination or a necessity? Obes Surg. 2017;27(5):1387–90.PubMedCrossRefGoogle Scholar
  49. 49.
    Tariciotti L, D'Ugo S, Manzia TM, Tognoni V, Sica G, Gentileschi P, et al. Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report. Int J Surg Case Rep. 2016;28:38–41.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    ASMBS Clinical Issues Committee. Updated position statement on sleeve gastrectomy as a bariatric procedure. Surg Obes Relat Dis. 2012;8(3):e21–6.CrossRefGoogle Scholar
  51. 51.
    Kramer H, Luke A. Obesity and kidney disease: a big dilemma. Curr Opin Nephrol Hypertens. 2007;16(3):237–41.PubMedCrossRefGoogle Scholar
  52. 52.
    Saran R, Robinson B, Abbott KC, Agodoa LY, Ayanian J, Bragg-Gresham J, et al. US renal data system 2016 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2017;69(3s1):A7–a8.PubMedCrossRefGoogle Scholar
  53. 53.
    Kim Y, Chang AL, Wima K, Ertel AE, Diwan TS, Abbott DE, et al. The impact of morbid obesity on resource utilization after renal transplantation. Surgery. 2016;160(6):1544–50.PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Park TL, Perri MG, Rodrigue JR. Minimal intervention programs for weight loss in heart transplant candidates: a preliminary examination. Prog Transplant. 2003;13(4):284–8.PubMedCrossRefGoogle Scholar
  55. 55.
    Kienzl-Wagner K, Weissenbacher A, Gehwolf P, Wykypiel H, Ofner D, Schneeberger S. Laparoscopic sleeve gastrectomy: gateway to kidney transplantation. Surg Obes Relat Dis. 2017;13(6):909–15.PubMedCrossRefGoogle Scholar
  56. 56.
    MacLaughlin HL, Hall WL, Patel AG, Macdougall IC. Laparoscopic sleeve gastrectomy is a novel and effective treatment for obesity in patients with chronic kidney disease. Obes Surg. 2012;22(1):119–23.PubMedCrossRefGoogle Scholar
  57. 57.
    Ritz E. Bariatric surgery and the kidney-much benefit, but also potential harm. Clin Kidney J. 2013;6(4):368–72.PubMedCrossRefGoogle Scholar
  58. 58.
    Currie A, Chetwood A, Ahmed AR. Bariatric surgery and renal function. Obes Surg. 2011;21(4):528–39.PubMedCrossRefGoogle Scholar
  59. 59.
    Flores L, Osaba MJ, Andreu A, Moize V, Rodriguez L, Vidal J. Calcium and vitamin D supplementation after gastric bypass should be individualized to improve or avoid hyperparathyroidism. Obes Surg. 2010;20(6):738–43.PubMedCrossRefGoogle Scholar
  60. 60.
    Gehrer S, Kern B, Peters T, Christoffel-Courtin C, Peterli R. Fewer nutrient deficiencies after laparoscopic sleeve gastrectomy (LSG) than after laparoscopic Roux-Y-gastric bypass (LRYGB)-a prospective study. Obes Surg. 2010;20(4):447–53.PubMedCrossRefGoogle Scholar
  61. 61.
    Kim IK, Choi SH, Son S, MK J. Early weight gain after transplantation can cause adverse effect on transplant kidney function. Transplant Proc. 2016;48(3):893–6.PubMedCrossRefGoogle Scholar
  62. 62.
    Johnson CP, Gallagher-Lepak S, Zhu YR, Porth C, Kelber S, Roza AM, et al. Factors influencing weight gain after renal transplantation. Transplantation. 1993;56(4):822–7.PubMedCrossRefGoogle Scholar
  63. 63.
    van den Ham EC, Kooman JP, Christiaans MH, Nieman FH, van Hooff JP. Weight changes after renal transplantation: a comparison between patients on 5-mg maintenance steroid therapy and those on steroid-free immunosuppressive therapy. Trans Int Off J Eur Soc Organ Transplant. 2003;16(5):300–6.CrossRefGoogle Scholar
  64. 64.
    Lynch RJ, Ranney DN, Shijie C, Lee DS, Samala N, Englesbe MJ. Obesity, surgical site infection, and outcome following renal transplantation. Ann Surg. 2009;250(6):1014–20.PubMedCrossRefGoogle Scholar
  65. 65.
    Ayloo SM, D’Amico G, West-Thielke P, Bejarano-Pineda L, Tzvetanov I, Giulianotti PC, et al. Combined robot-assisted kidney transplantation and sleeve gastrectomy in a morbidly obese recipient. Transplantation. 2015;99(7):1495–8.PubMedCrossRefGoogle Scholar
  66. 66.
    Agopian VG, Kaldas FM, Hong JC, Whittaker M, Holt C, Rana A, et al. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg. 2012;256(4):624–33.PubMedCrossRefGoogle Scholar
  67. 67.
    Segev DL, Thompson RE, Locke JE, Simpkins CE, Thuluvath PJ, Montgomery RA, et al. Prolonged waiting times for liver transplantation in obese patients. Ann Surg. 2008;248(5):863–70.PubMedCrossRefGoogle Scholar
  68. 68.
    Murray KF, Carithers RL Jr. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology. 2005;41(6):1407–32.PubMedCrossRefGoogle Scholar
  69. 69.
    Mosko JD, Nguyen GC. Increased perioperative mortality following bariatric surgery among patients with cirrhosis. Clinical Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2011;9(10):897–901.Google Scholar
  70. 70.
    Lin MY, Tavakol MM, Sarin A, Amirkiai SM, Rogers SJ, Carter JT, et al. Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates. Surg Obes Relat Dis. 2013;9(5):653–8.PubMedCrossRefGoogle Scholar
  71. 71.
    Richards J, Gunson B, Johnson J, Neuberger J. Weight gain and obesity after liver transplantation. Transpl Int Off J Eur Soc Organ Transplant. 2005;18(4):461–6.CrossRefGoogle Scholar
  72. 72.
    Perkins JD. Influence of obesity with concurrent diseases on liver transplant survival. Liver Transpl. 2007;13(6):928–9.PubMedCrossRefGoogle Scholar
  73. 73.
    Lazzati A, Iannelli A, Schneck AS, Nelson AC, Katsahian S, Gugenheim J, et al. Bariatric surgery and liver transplantation: a systematic review a new frontier for bariatric surgery. Obes Surg. 2015;25(1):134–42.PubMedCrossRefGoogle Scholar
  74. 74.
    Tsamalaidze L, Stauffer JA, Arasi LC, Villacreses DE, Franco JSS, Bowers S, et al. Laparoscopic sleeve gastrectomy for morbid obesity in patients after orthotopic liver transplant: a matched case-control study. Obes Surg. 2017. [Epub ahead of print].Google Scholar
  75. 75.
    Tichansky DS, Madan AK. Laparoscopic Roux-en-Y gastric bypass is safe and feasible after orthotopic liver transplantation. Obes Surg. 2005;15(10):1481–6.PubMedCrossRefGoogle Scholar
  76. 76.
    Duchini A, Brunson ME. Roux-en-Y gastric bypass for recurrent nonalcoholic steatohepatitis in liver transplant recipients with morbid obesity. Transplantation. 2001;72(1):156–9.PubMedCrossRefGoogle Scholar
  77. 77.
    Duailibi DF, Ribeiro MA Jr. Biliary complications following deceased and living donor liver transplantation: a review. Transplant Proc. 2010;42(2):517–20.PubMedCrossRefGoogle Scholar
  78. 78.
    Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009;53(15):e1–e90.PubMedCrossRefGoogle Scholar
  79. 79.
    Prabhakaran D, Roy A, Praveen PA, Ramakrishnan L, Gupta R, Amarchand R, et al. 20-year trend of cardiovascular disease risk factors: Urban and Rural National Capital Region of Delhi, India. Glob Heart. 2017. pii: S2211-8160(16)30787-6. [Epub ahead of print].Google Scholar
  80. 80.
    Wong C, Marwick TH. Obesity cardiomyopathy: diagnosis and therapeutic implications. Nat Clin Pract Cardiovasc Med. 2007;4(9):480–90.PubMedCrossRefGoogle Scholar
  81. 81.
    Lund LH, Edwards LB, Kucheryavaya AY, Dipchand AI, Benden C, Christie JD, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Official Adult Heart Transplant Report – 2013; focus theme: age. J Heart Lung Transplant. 2013;32(10):951–64.PubMedCrossRefGoogle Scholar
  82. 82.
    Weiss ES, Allen JG, Russell SD, Shah AS, Conte JV. Impact of recipient body mass index on organ allocation and mortality in orthotopic heart transplantation. J Heart Lung Transplant. 2009;28(11):1150–7.PubMedCrossRefGoogle Scholar
  83. 83.
    Bozso SJ, Nagendran J, Gill RS, Freed DH, Nagendran J. Impact of obesity on heart and lung transplantation: does pre-transplant obesity affect outcomes? Transplant Proc. 2017;49(2):344–7.PubMedCrossRefGoogle Scholar
  84. 84.
    Nagendran J, Moore MD, Norris CM, Khani-Hanjani A, Graham MM, Freed DH, et al. The varying effects of obesity and morbid obesity on outcomes following cardiac transplantation. Int J Obes (2005). 2016;40(4):721–4.CrossRefGoogle Scholar
  85. 85.
    Wikiel KJ, McCloskey CA, Ramanathan RC. Bariatric surgery: a safe and effective conduit to cardiac transplantation. Surg Obes Relat Dis. 2014;10(3):479–84.PubMedCrossRefGoogle Scholar
  86. 86.
    Ristow B, Rabkin J, Haeusslein E. Improvement in dilated cardiomyopathy after bariatric surgery. J Card Fail. 2008;14(3):198–202.PubMedCrossRefGoogle Scholar
  87. 87.
    McCloskey CA, Ramani GV, Mathier MA, Schauer PR, Eid GM, Mattar SG, et al. Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy. Surg Obes Relat Dis. 2007;3(5):503–7.PubMedCrossRefGoogle Scholar
  88. 88.
    Jeng EI, Aranda JM Jr, Ahmed M, Klodell CT. Left ventricular assist device and bariatric surgery: a bridge to heart transplant by weight and waiting time reduction. J Card Surg. 2016;31(2):120–2.PubMedCrossRefGoogle Scholar
  89. 89.
    Lake KD, Reutzel TJ, Pritzker MR, Jorgensen CR, Emery RW. The impact of steroid withdrawal on the development of lipid abnormalities and obesity in heart transplant recipients. J Heart Lung Transplant. 1993;12(4):580–90.PubMedGoogle Scholar
  90. 90.
    Winters GL, Kendall TJ, Radio SJ, Wilson JE, Costanzo-Nordin MR, Switzer BL, et al. Posttransplant obesity and hyperlipidemia: major predictors of severity of coronary arteriopathy in failed human heart allografts. J Heart Transplant. 1990;9(4):364–71.PubMedGoogle Scholar
  91. 91.
    Williams JJ, Lund LH, LaManca J, Kunavarapu C, Cohen DJ, Heshka S, et al. Excessive weight gain in cardiac transplant recipients. J Heart Lung Transplant. 2006;25(1):36–41.PubMedCrossRefGoogle Scholar
  92. 92.
    Ladowski JS, Kormos RL, Uretsky BF, Lee A, Curran M, Clark R, et al. Posttransplantation diabetes mellitus in heart transplant recipients. J Heart Transplant. 1989;8(2):181–3.PubMedGoogle Scholar
  93. 93.
    Tsamalaidze L, Elli EF. Bariatric surgery is gaining ground as treatment of obesity after heart transplantation: report of two cases. Obes Surg. 2017. [Epub ahead of print].Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of General SurgeryMayo Clinic FloridaJacksonvilleUSA

Personalised recommendations